These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11342351)

  • 1. Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia.
    Sarmiento MA; Neme D; Fornari MC; Bengió RM
    Leuk Lymphoma; 2000 Nov; 39(5-6):657-9. PubMed ID: 11342351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
    Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
    J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Koczwara B; Spangenthal E; Bernstein SH
    Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution.
    Grey MR; Flanagan NG; Kelsey PR
    Clin Lab Haematol; 2000 Apr; 22(2):111-3. PubMed ID: 10792402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antibodies reacting with two neighboring gangliosides are induced in rabbits immunized with bovine brain gangliosides.
    Moyano AL; Comín R; Vilcaes AA; Funes SC; Roth GA; Irazoqui FJ; Nores GA
    Glycobiology; 2012 Dec; 22(12):1768-74. PubMed ID: 22843673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine].
    Nielsen OJ; Hippe E; Priø TK; Juliusson G
    Ugeskr Laeger; 1994 Apr; 156(16):2407-9. PubMed ID: 7912015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome.
    Morgan ML; Law N; Espino Barros Palau A; Saeed U; Yalmanchili S; Lee AG
    J Neuroophthalmol; 2014 Dec; 34(4):377-9. PubMed ID: 25062498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome].
    Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S
    Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
    Juliusson G; Heldal D; Hippe E; Hedenus M; Malm C; Wallman K; Stolt CM; Evensen SA; Albertioni F; Tjønnfjord G
    J Clin Oncol; 1995 Apr; 13(4):989-95. PubMed ID: 7707128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies to GM1 and GQ1b gangliosides].
    Obayashi H; Saida T; Fukui M; Hasegawa G; Nakamura N; Yoshikawa T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():653-5. PubMed ID: 16111360
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine].
    Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S
    Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.